EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Synthesis and In Vitro Metabolic Profiling of the Selective Androgen Receptor Modulator (SARM) LY305

Giorgi Kobidze, Tristan Möller, Hui-Chung Wen, Francesco Paolo Busardò, Mario Thevis

Rapid Communications in Mass Spectrometry · 2025

DOI: 10.1002/rcm.10124 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Rapid Communications in Mass Spectrometry, 2025. Verfasst von Giorgi Kobidze und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Excellence-Biomedical Sciences and Public Health, Università Politecnica Delle Marche, Ancona, Italy. Hauptthemen laut MEDLINE: Receptors, Androgen, Anabolic Agents, Nitriles. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Manfred Donike Institut für Dopinganalytik, Bundesministerium des Innern, für Bau und Heimat, United States Anti-Doping Agency (USADA).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rationale

2‐Chloro‐4‐[[(1R,2R)‐2‐hydroxy‐2‐methyl‐cyclopentyl]amino]‐3‐methyl‐benzonitrile (LY305) is a transdermal selective androgen receptor modulator (SARM) that has been under development as a potential therapeutic for conditions involving muscle wasting, osteoporosis, or hypogonadism. Due to its proven anabolic effects, its potential (and illicit) use in sport must be taken into consideration, necessitating information on its biotransformation for the implementation of adequate target analytes into routine doping control analytical procedures. In this study, the synthesis of LY305 and in vitro‐derived metabolites of the SARM are described.

Methods

LY305 was synthesized by a Buchwald–Hartwig amination using 2‐chloro‐4‐iodo‐3‐methylbenzonitrile and (1 R ,2 R )‐2‐amino‐1‐methyl‐cyclopentanol. The in vitro metabolism experiments were conducted using human liver microsomes (HLM) and the S9 fraction to allow for studying phase‐I and phase‐II biotransformations. For the detection and separation of LY305 and its metabolites, liquid chromatography–high‐resolution tandem mass spectrometry was used.

Results

Overall, 18 metabolites were detected, nine of which were identified as phase‐I metabolites and an additional nine were attributed to phase‐II conjugates. Metabolic reactions were as follows: hydroxylation, dehydrogenation, oxidation, oxidation and hydroxylation, O‐ glucuronidation, hydroxylation with subsequent glucuronidation, and bis‐hydroxylation with subsequent glucuronidation.

Conclusions

The transdermal SARM LY305 was successfully synthesized and subjected to in vitro metabolic studies, yielding chromatographic and mass spectral data that support improving comprehensive anti‐doping tests. To the best of our knowledge, no published experimental data exist that report on the in vitro metabolic profile of LY305, a substance that might undergo further (pre)clinical evaluation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, AndrogenAnabolic AgentsNitrilesHumansMicrosomes, LiverTandem Mass SpectrometryDoping in Sports

Stichwörter der Autor:innen

HPLC‐HRMSLY305SARMdopingphase‐I metabolitesphase‐II metabolites

Substanzen

Receptors, AndrogenAnabolic AgentsNitriles

Autor:innen und Institutionen

  • Department of Excellence-Biomedical Sciences and Public Health, Università Politecnica Delle Marche, Ancona, Italy.
  • Center for Preventive Doping Research, Institute of Biochemistry, German Sport University Cologne, Cologne, Germany.
  • Faculty of Chemistry, University of Cologne, Cologne, Germany.

Förderung

  • Manfred Donike Institut für Dopinganalytik
  • Bundesministerium des Innern, für Bau und Heimat
  • United States Anti-Doping Agency (USADA)

Zitieren

APA

Kobidze, G., Möller, T., Wen, H. C., Busardò, F. P., & Thevis, M. (2025). Synthesis and In Vitro Metabolic Profiling of the Selective Androgen Receptor Modulator (SARM) LY305. Rapid Communications in Mass Spectrometry. https://doi.org/10.1002/rcm.10124

Vancouver

Kobidze G, Möller T, Wen HC, Busardò FP, Thevis M. Synthesis and In Vitro Metabolic Profiling of the Selective Androgen Receptor Modulator (SARM) LY305. Rapid Communications in Mass Spectrometry. 2025. doi:10.1002/rcm.10124

BibTeX
@article{Kobidze2025,
  author = {Kobidze, Giorgi and Möller, Tristan and Wen, Hui-Chung and Busardò, Francesco Paolo and Thevis, Mario},
  title = {Synthesis and In Vitro Metabolic Profiling of the Selective Androgen Receptor Modulator (SARM) LY305},
  journal = {Rapid Communications in Mass Spectrometry},
  year = {2025},
  doi = {10.1002/rcm.10124}
}
Kostenlos starten →